Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
Alessio De Rose, Nutrition Manager at S.S. Lazio, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nutrients, adding:
“I am thrilled to share our recently published article in Nutrients:
‘Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency’
Incretin receptor agonist-based therapies, including GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists, have significantly changed the management of type 2 diabetes, overweight, and obesity.
As their clinical use continues to expand, it is becoming increasingly important to consider not only their metabolic benefits, but also their potential nutritional implications.
In this perspective article, we discuss emerging evidence on the possible association between incretin-based therapies and iron deficiency/iron deficiency anemia, explore the potential underlying mechanisms, and propose practical strategies for prevention, biochemical monitoring, and clinical-nutritional management.
This work highlights the importance of integrating pharmacological innovation with careful nutritional assessment and individualized patient care.
I am grateful to all co-authors and collaborators for their valuable contribution to this work.”
Title: Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency
Authors: Marco Infante, Camillo Ricordi, Francesca Pacifici, Donatella Pastore, Raffaele Infante, Massimiliano Caprio, Francesca Chiereghin, Alessandro De Stefano, Giulia Frank, Alessio De Rose, Lorenzo Romano, Laura Di Renzo, Valentina Rovella, Antonino De Lorenzo, Giulia Donadel, David Della-Morte
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas LangÖ‰ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge
-
Sep 29, 2026, 16:18Edward Lee Carter: Why Periprocedural DOAC Guidance Needs a Common Output Standard
-
Sep 29, 2026, 16:07Yasmine Laraba: Deep Vein Thrombosis Causes, Signs and Management